The investment objective of the C WorldWide Medical fund is to achieve long-term capital growth through global investment in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors. The emphasis is on large-cap companies, however a considerable part of the portfolio consists of mid and small-cap companies. These are often more difficult to value and less analyzed than large cap companies.
|C WorldWide Medical||Benchmark|
TOP 10 HOLDINGS
|Share in %|
|Unitedhealth Group||6.8 %|
|Johnson & Johnson||6.5 %|
|Gilead Sciences||5.1 %|
|Roche Hld.||4.8 %|
|C WorldWide Medical Small & Mid Cap||4.1 %|
|Novartis Holding||3.9 %|
|Merck & Co||3.8 %|
RETURN & RISK
|1 Y||3 Y||5 Y||10 Y||Lifetime||P.A.|
|C WorldWide Medical (%)||-0.2||7.4||13.6||6.1||8.6||8.6|
|Relative performance (%)||-6.9||-6.6||-4.3||-3.9||2.4||2.4|
|3 Y||5 Y||10 Y||Lifetime||P.A.|
|Std. dev. portfolio (%)||19.0||16.5||15.2||17.9||17.9|
|Std. dev. benchmark (%)||15.0||12.8||13.0||13.4||13.4|
|Security identifier (ISIN):||LU0090908194|
|Launch date:||15 December 1998|
|Management fee:||1.70% per annum|
|Minimum investment:||EUR 1,000|
|Benchmark:||MSCI World Healthcare Index|
|NAV at month end:||92.26|
|Fund AUM:||549.5 million|
|Investment Manager:||C WorldWide Asset Management, Stockholm|
|Portfolio Manager:||Angelica Fatouros|
The fact sheet is for information purposes only. The fact sheet does not constitute, and shall not be considered as, an offer or invitation to purchase or sell any fund. The information, calculations etc. shall not be considered investment advice or requests to engage in investment operations.
All reasonable precautions have been taken to ensure the correctness and accuracy of the fact sheet. However, the correctness and accuracy is not guaranteed and C WorldWide Asset Management Fondsmaeglerselskab A/S accepts no liability for any errors, spelling mistakes or omissions.
It is emphasized that the figures in the fact sheet are historical, and that past performance is no reliable indicator of future performance.